MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...

Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) ...

Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...

Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.

In late November Abbott—one of Dexcom’s main competitors— recalled some of its CGMs due to inaccurate low glucose readings.

DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 10.25% on an annualized basis producing an average annual return of 22.3%. Currently, DexCom has a market capitalization of ...

Insulet Corporation PODD recently received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new ...

EDINBURGH, Scotland--(BUSINESS WIRE)-- DexCom, Inc. (DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of Dexcom Academy, a ...

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. DexCom made certain product changes without FDA authorization. The Company's product changes ...

[Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) today announced the launch of Dexcom Academy, a new, personalized learning platform for healthcare professionals (HCPs). Guided by HCP insights, the ...

DexCom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of Dexcom Academy, a new personalised learning ...